High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$683K
$683,842
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| MAZE |
Maze Therapeutics, Inc.
|
Officer • SVP, Finance
Other
|
2026-03-02 | $52,100 | M | Form 4 |
|
MAZE
S
Maze Therapeutics, Inc.
Bachrodt Amy
• Officer • SVP, Finance
10b5-1 Sell
2026-03-02
$226,011x2
|
||||||
| MAZE |
Maze Therapeutics, Inc.
|
Officer • SVP, Finance
10b5-1 Sell
|
2026-03-02 | $226,011x2 | S | Form 4 |
| MAZE |
Maze Therapeutics, Inc.
|
Officer • SVP, Finance
Other
|
2026-02-02 | $52,100x2 | M | Form 4 |
|
MAZE
S
Maze Therapeutics, Inc.
Bachrodt Amy
• Officer • SVP, Finance
10b5-1 Sell
2026-02-02
$230,219x3
|
||||||
| MAZE |
Maze Therapeutics, Inc.
|
Officer • SVP, Finance
10b5-1 Sell
|
2026-02-02 | $230,219x3 | S | Form 4 |
| MAZE |
Maze Therapeutics, Inc.
|
Officer • SVP, Finance
Other
|
2026-01-22 | $52,100x2 | M | Form 4 |
|
MAZE
S
Maze Therapeutics, Inc.
Bachrodt Amy
• Officer • SVP, Finance
10b5-1 SellΔOwn -27.8%
2026-01-22
$227,612
|
||||||
| MAZE |
Maze Therapeutics, Inc.
|
Officer • SVP, Finance
10b5-1 SellΔOwn -27.8%
|
2026-01-22 | $227,612 | S | Form 4 |